Covid-19: The Industry Response – How Are we Doing?
Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and … Continue reading “Covid-19: The Industry Response – How Are we Doing?”
Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and … Continue reading “Covid-19: The Industry Response – How Are we Doing?”
This year, in collaboration with Dechert, we held a virtual version of … Continue reading “Desperately Seeking Serendipity – Engaging in the new virtual”
Check out the full agenda and speakers via the conference website. Register now.
Optimum’s 12th Annual Healthcare Investor Conference features panel with eminent industry leaders. Read more here and register your interest to join the virtual event live on 8th October 2020
co-hosted with Dechert LLP, Thursday 8th October 2020. The first speakers to be announced…
A video panel by Optimum in partnership with One Nucleus for ON Helix event held virtually in July 2020
Phase 2 data from Arix portfolio company Amplyx and why anti-infectives are especially important now during the pandemic.
Who are the women blazing trails in biopharma R&D and leading the fight against Covid-19?
Optimum is proud to sponsor the 2020 European Mediscience Award for Best … Continue reading “Optimum sponsors of the European Mediscience Award for Best Communications”
Read more on VelosBio in this latest blog post by Arix Managing Director and VelosBio Board Director Jonathan Tobin
As many countries continue to pass the peak of COVID-19, Masters Speciality … Continue reading “Pharmaceuticals vs Covid-19 | Half-Time Report by Sid Masters, Masters Pharma”
The Optimum Strategic Communications European VC Report confirmed that there is a … Continue reading “Recommendations following our EU Healthcare Investor Survey 2020”
Since taking over as CEO of Calliditas Therapeutics in 2017, Renee Aguiar-Lucander … Continue reading “Optimum Video Q&A: Getting to know Renee Aguiar-Lucander”
Are you sitting comfortably? Do you notice your breathing, all nice and easy? Now, try taking a straw and breathing just through that. Not quite so easy is it?
This is a fantastic initiative that helps young businesses by providing the support they need to succeed. This includes up to USD 500,000 in fundraising, introduction to a dynamic network and access to free lab space.
Has Kiadis Found Immunotherapy’s Killer App? In Amsterdam, there has just been a glimpse of the future of cellular medicine.
European investors continue actively investing in healthcare. The survey held in May 2020 includes responses from 24 of the most influential European VCs, investing approximately EUR 15.5 billion in aggregate in the Healthcare sector.
Watch the full interview here Mike Ward, Global Head of Thought Leadership, … Continue reading “Optimum Q&A: Getting to know Dr. Cedric Francois, CEO of Apellis Pharmaceuticals”
Today, on International Nurses Day, at a time when clinical trials are being discussed on a daily basis regarding the COVID-19 crisis, Cure Leukaemia highlights how the crisis could impact blood cancer patients
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...
GET IN TOUCH
© Copyright 2021 Optimum Strategic Communications All rights reserved.
8 Devonshire Square
Spitalfields
London
EC2M 4PL
Tel: +44 (0)203 950 9144
Email: contact@optimumcomms.com
